As of June 3, 2025, Yourgene Health PLC (YGEN.L) reports a Net Margin of -5.10%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Yourgene Health PLC's Net Margin
Over recent years, Yourgene Health PLC's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2022-03-31 | -5.10% |
| 2021-03-31 | -66.62% |
| 2020-03-31 | -14.65% |
| 2019-03-31 | 38.16% |
| 2018-03-31 | -154.27% |
This slight upward trend highlights how Yourgene Health PLC manages its overall profitability and cost control over time.
Comparing Yourgene Health PLC's Net Margin to Peers
To better understand Yourgene Health PLC's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Yourgene Health PLC (YGEN.L) | -5.10% |
| Titan Medical Inc (TMD.TO) | 39.43% |
| Sectra AB (SECT B.ST) | 24.83% |
| NanoRepro AG (NN6.DE) | 18.27% |
| Surgical Science Sweden AB (SUS.ST) | 14.89% |
| C Rad AB (CRAD B.ST) | 12.04% |
Compared to its competitors, Yourgene Health PLC's Net Margin is about average compared to peers, reflecting typical industry profitability.